Two Sigma Advisers’s Chemours CC Stock Holding History

Two Sigma Advisers’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,600	Closed	-$278K	–	377
2025 Q4	$278K	Sell	23,600 -161,400	-87%	-$2.07M	﹤0.01%	2004
2025 Q3	$2.93M	Sell	185,000 -680,500	-79%	-$9.87M	0.01%	957
2025 Q2	$9.91M	Buy	865,500 +19,900	+2%	+$224K	0.02%	507
2025 Q1	$11.4M	Buy	845,600 +184,100	+28%	+$3.06M	0.03%	487
2024 Q4	$11.2M	Buy	661,500 +158,400	+31%	+$3.08M	0.03%	454
2024 Q3	$10.2M	Buy	503,100 +43,200	+9%	+$883K	0.02%	482
2024 Q2	$10.4M	Buy	459,900 +273,900	+147%	+$7.17M	0.02%	528
2024 Q1	$4.88M	Sell	186,000 -33,400	-15%	-$952K	0.01%	790
2023 Q4	$6.92M	Buy	219,400 +184,600	+530%	+$5.01M	0.02%	675
2023 Q3	$976K	Buy	34,800 +23,800	+216%	+$817K	﹤0.01%	1534
2023 Q2	$406K	Sell	11,000 -150,900	-93%	-$4.61M	﹤0.01%	1881
2023 Q1	$4.85M	Sell	161,900 -75,200	-32%	-$2.48M	0.01%	822
2022 Q4	$7.26M	Sell	237,100 -117,800	-33%	-$3.53M	0.02%	620
2022 Q3	$8.75M	Sell	354,900 -113,200	-24%	-$3.73M	0.03%	532
2022 Q2	$15M	Buy	468,100 +61,400	+15%	+$2.26M	0.04%	389
2022 Q1	$12.8M	Sell	406,700 -600	-0.1%	-$18.8K	0.03%	433
2021 Q4	$13.7M	Sell	407,300 -29,700	-7%	-$925K	0.03%	414
2021 Q3	$12.7M	Sell	437,000 -164,500	-27%	-$5.33M	0.03%	445
2021 Q2	$20.9M	Sell	601,500 -281,800	-32%	-$9.33M	0.06%	327
2021 Q1	$24.7M	Sell	883,300 -40,400	-4%	-$1.07M	0.07%	307
2020 Q4	$22.9M	Buy	923,700 +53,000	+6%	+$1.26M	0.06%	317
2020 Q3	$18.2M	Sell	870,700 -132,100	-13%	-$2.55M	0.05%	343
2020 Q2	$15.4M	Buy	1,002,800 +72,000	+8%	+$910K	0.05%	397
2020 Q1	$8.26M	Buy	930,800 +522,200	+128%	+$7.53M	0.03%	549
2019 Q4	$7.39M	Buy	408,600 +323,700	+381%	+$5.38M	0.02%	699
2019 Q3	$1.27M	Buy	84,900 +2,400	+3%	+$39K	﹤0.01%	1328
2019 Q2	$1.98M	Sell	82,500 -109,700	-57%	-$3.23M	﹤0.01%	1210
2019 Q1	$7.14M	Sell	192,200 -108,100	-36%	-$3.93M	0.02%	719
2018 Q4	$8.47M	Sell	300,300 -86,543	-22%	-$2.74M	0.02%	616
2018 Q3	$15.3M	Sell	386,843 -716,200	-65%	-$31.3M	0.04%	464
2018 Q2	$48.9M	Sell	1,103,043 -396,700	-26%	-$19.7M	0.13%	196
2018 Q1	$73.1M	Sell	1,499,743 -164,000	-10%	-$8.2M	0.2%	139
2017 Q4	$83.3M	Sell	1,663,743 -1,110,536	-40%	-$58.2M	0.22%	117
2017 Q3	$140M	Buy	2,774,279 +134,659	+5%	+$6.35M	0.4%	56
2017 Q2	$100M	Buy	2,639,620 +149,277	+6%	+$5.89M	0.33%	67
2017 Q1	$95.9M	Buy	2,490,343 +825,916	+50%	+$24.9M	0.31%	74
2016 Q4	$36.8M	Buy	1,664,427 +1,202,827	+261%	+$24.7M	0.14%	171
2016 Q3	$7.39M	Buy	461,600 +130,800	+40%	+$1.49M	0.03%	506
2016 Q2	$2.73M	Sell	330,800 -53,100	-14%	-$473K	0.01%	751
2016 Q1	$2.69M	Buy	383,900 +92,200	+32%	+$463K	0.02%	686
2015 Q4	$1.56M	Buy	291,700 +279,500	+2,291%	+$1.79M	0.01%	837
2015 Q3	$118K	Buy	+12,200	New	+$128K	﹤0.01%	1706

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Advisers's CC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Chemours (CC) in Q1 2026, closing a stake of 23,600 shares — an estimated $278K sold.

Two Sigma Advisers first reported a position in CC in Q3 2015 and held it in 42 quarters. The position peaked at $140M in Q3 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

Two Sigma Advisers reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 23,600 Chemours shares in Q1 2026, an estimated $278K.
Two Sigma Advisers first reported a position in Chemours in Q3 2015 and held it in 42 quarters.
Two Sigma Advisers's Chemours position peaked at $140M in Q3 2017.
448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.